Minireview: Constitutively active G protein-coupled receptors: Potential mechanisms of receptor activation

Journal of Receptor and Signal Transduction Research

Volumn 17, Issue 42007, 1997, Pages 57-73

  Scheer, Alexander ^a   Cotecchia, Susanna ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; INTERMEDIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE RECEPTOR; MUSCARINIC RECEPTOR; RHODOPSIN; THROMBIN; THROMBIN RECEPTOR; THYROTROPIN; THYROTROPIN RECEPTOR;

ALLOSTERISM; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; DRUG RECEPTOR BINDING; GENETIC TRANSDUCTION; HYPERPIGMENTATION; MOLECULAR DYNAMICS; NIGHT BLINDNESS; POINT MUTATION; PRECOCIOUS PUBERTY; PROTEIN ANALYSIS; RETINITIS PIGMENTOSA; SITE DIRECTED MUTAGENESIS; THERMODYNAMICS;

GTP-BINDING PROTEINS; HUMANS; ISOMERISM; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; RECEPTORS, CELL SURFACE;

EID: 0031029841     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899709036594     Document Type: Article

References (46)

1. Khorana H. G. Rhodopsin, photoreceptor of the rod cell. J. Biol. Chem. 1992; 267: 1 – 4
2. Savarese T. M., Fraser C. M. In vitro mutagenesis and the search for structure function relationships among G protein-coupled receptors. Biochem. J. 1992; 283: 1 – 19
3. Cotecchia S., Exum S., Caron M. G., Lefkowitz R. J. Regions of α1-adrenergic receptor involved in coupling to phosphatidyl-inositol hydrolysis and enhanced sensivity of biological function. Proc. Natl. Acad. Sci. USA 1990; 87: 2896 – 2900
4. Kjelsberg M. A., Cotecchia S., Ostrowski J., Caron M. G., Lefkowitz R. J. Constitutive activation of the α1B-adrenergic receptor by all amino acid substitution at a single site. J. Biol. Chem. 1992; 267: 1430 – 1433
5. Samama P., Cotecchia S., Costa T., Lefkowitz R. J. A mutation-induced activated state of the β2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 1993; 268: 4625 – 4636
6. Ren Q., Kurose H., Lefkowitz R. J., Cotecchia S. Constitutively active mutants of the α2A-adrenergic receptor. J. Biol. Chem. 1993; 268: 16483 – 16487
7. Högger P., Shockley M. S., Lameh J., Sadee W. Activating mutations in N- and C-terminal 13 loop junctions of muscarinic acetylcholine Hm1 receptors. J. Biol. Chem. 1995; 270: 7405 – 7410
8. Boone C., Davis N. G., Sprague G. F., Jr. Mutations that alter the third cytoplasmatic loop of the a-factor receptor lead to constitutive and hypersensitive phenotype. Proc. Natl. Acad. Sci. USA 1993; 90: 9921 – 9258
9. Blüml K., Mutschler E., Wess J. Functional role in ligand binding and receptor activation of an asparagine residue present in the sixth transmembrane domain of all muscarinic acetylcholine receptors. J. Biol. Chem. 1994; 269: 18870 – 18876
10. Spalding T. A., Burstein E. S., Brauner-Osbourne H., Hill-Eubanks D., Brann M. R. Pharmacology of a constitutively active muscarinic receptor generated by random mutagenesis. J. Pharmacol. Exp. Ther. 1996; 275: 1274 – 1279
11. Nanevicz T., Wang L., Chen M., Ishii M., Coughlin S. R. Thrombin receptor activating mutations. J. Biol. Chem. 1996; 271: 702 – 706
12. Burstein E. S., Spalding T. A., Brann M. R. Constitutive activation of chimeric m2/m5 muscarinic receptors and dileneation of G-protein coupling selectivity domains. Biochem. Pharmacol. 1996; 51: 539 – 544
13. Perez D. M., Hwa J., Gaivin R., Mathur M., Brown F., Graham R. M. Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 1996; 49: 112 – 122
14. Robinson P. R., Cohen G. B., Zhukovsky E. A., Oprian D. D. Constitutively active mutants of rhodopsin. Neuron 1992; 9: 719 – 725
15. Rao V. R., Cohen G. B., Oprian D. D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature 1994; 367: 639 – 642
16. Dryga T. P., Berson E. L., Rao V. R., Oprian D. D. Heterozygous missence mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nature Genet. 1993; 4: 280 – 283
17. Shenker A., Laue L., Kosugi S., Merenddino J. J., Jr, Minegishi T., Cutler G. B., Jr. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 1993; 365: 652 – 654
18. Kosugi S., Van Dop C., Geffner M. E., Rabl W., Carel J. C., Chaussain J. L., Mori T., Merendino J. J., Jr, Shenker A. Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum. Mol. Genet. 1995; 4: 183 – 188
19. Parma J., Duprez L., Van Sande J., Cochaux P., Gervy C., Mockel J., Dumont J., Vassart G. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 1993; 365: 649 – 651
20. Parma J., Van Sande J., Swillens S., Tonacchera M., Dumont J., Vassart G. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyper-functioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades. Mol. Endocrinol. 1995; 9: 725 – 733
21. Duprez L., Parma J., Van Sande J., Allgeier A., Leclère J., Schvartz C., Delisle M.-J., Decoulx M., Orgiazzi J., Dumont J., Vassart G. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nature Genet. 1994; 7: 396 – 401
22. Paschke R., Tonacchera M., Van Sande J., Parma J., Vassart G. Identification and functional characterization of two new somatic mutations causing constitutive activation of the thyrotropin receptor in hyperfunctioning autonomous adenomas of the thyroid. J. Clin. Endocrinol. Meta. 1994; 79: 1785 – 1789
23. Robbins L. S., Nadeau J. H., Johnson K. R., Kelly M. A., Roselli-Rehfuss L., Baack E., Mountjoy K. G., Cone R. D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993; 72: 827 – 34
24. Schipani E., Kruse K., Jüppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 1995; 268: 98 – 100
25. Del Castillo J., Katz B. Interaction at end-plate receptors between different choline derivates. Proc. R. Soc. Lond. B. Biol. Sci. 1957; 146: 369 – 381
26. DeLean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J. Biol. Chem. 1980; 268: 4625 – 4636
27. Tiberi M., Caron M. High agonist-independent activity is a distinguishing feature of the dopamine DIB receptor subtype. J. Biol. Chem. 1994; 269: 27295 – 27931
28. Cetani F., Tonacchera M., Vassart G. Differential effects of NaCl concentration on the constitutive activity of the thyrotropin and the luteinizing hormone/chorionic gonadotropin receptors. FEBS Lett. 1996; 378: 27 – 31
29. Costa T., Ogino Y., Munson P. J., Onaran H. O., Rodbard D. Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand. Mol. Pharmacol. 1992; 41: 549 – 560
30. Schütz W., Freissmuth M. Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 1992; 13: 376 – 380
31. Milligan G., Bond R. A., Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy?. Trends Pharmacol. Sci. 1995; 16: 10 – 13
32. Chidiac P., Hebert T. E., Valiquette M., Dennis M., Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 1994; 45: 490 – 499
33. Samama P., Pei G., Costa T., Coteccha S., Lefkowitz R. J. Negative Antagonists promote an inactive conformation of the β2-adrenergic receptor. Mol. Pharmacol. 1994; 45: 390 – 394
34. Barker E. L., Westphal R. S., Schmidt D., Sanders-Bush E. Constitutively active 5-hydroxytryptamine2c receptor reveal novel inverse agonist activity of receptor ligands. J. Biol. Chem. 1994; 269: 11687 – 11690
35. Leeb-Lundberg L. M. F., Mathis S. A., Herzig M. C. S. Antagonists of Bradykinin that stabilize a G-protein-uncoupled state of the B2 receptor act as inverse agonists in rat myometrial cells. J. Biol. Chem. 1994; 269: 25970 – 25973
36. Cohen G. B., Oprian D. D., Robinson P. R. Mechanism of activation and inactivation of opsin: role of Glu113 and Lys296. Biochemistry 1992; 31: 12592 – 12601
37. Arnis S., Fahmy K., Hofmann K. P., Sakmar T. P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 1994; 269: 23879 – 23881
38. Farahbakhsh Z. T., Ridge K. D., Khorana H. G., Hubbell W. L. Mapping light-dependent structural changes in the cyto-plasmatic loop connecting helices C and D in rhodopsin: a site directed spin labeling study. Biochemistry 1995; 34: 8812 – 8819
39. Cohen G. B., Yang T., Robinson P. R., Oprian D. D. Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry 1993; 32: 6111 – 6115
40. Sakmar T. P., Franke R. R., Khorana H. G. Glutamic acid-113 serves as the retinylidene Schiff base counterion in bovine rhodopsin. Proc. Natl. Acad. Sci. USA 1989; 86: 8309 – 8313
41. Franke R. R., König B., Sakmar T. P., Khorana H. G., Hofmann K. P. Rhodopsin mutants that bind but fail to activate transducin. Science 1990; 250: 132 – 125
42. Scheer A., Fanelli F., Costa T., De Benedetti P. G., Cotecchia S. Constitutively active mutants of the α1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J.
43. Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., Hibert M. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J. Med. Chem. 1992; 35: 3448 – 3462
44. Oliveira L., Paiva A. C. M., Sander C., Vriend G. A common step for signal transduction in G protein-coupled receptors. Trends Pharmacol. Sci. 1994; 15: 170 – 172
45. Fanelli F., Menziani M. C, De Benedetti P. G. Computer simulations of signal transduction mechanism in α1B-adrenergic and m3-muscarinic receptors. Protein Eng., 8: 557 – 564
46. Baldwin J. M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 1993; 12: 1693 – 1703